Drug resistant tumour models

EPO has available several mouse and human tumour models with acquired drug-resistance.

Drug-resistance was induced by in vitro or in vivo treatment of tumours with the corresponding agent or by transduction of corresponding genes.

The models are suitable for in vitro or in vivo investigations concerning the potential of a novel compound to overcome resistance (sensitizer) or to examine a drug for cross-resistance. The models are characterised for mechanisms of resistance (multidrug resistance, hormonal).
 

 

Schematic cartoon of PGP function


 

Origin Model / resistant to

Mouse

P388 / Adriablastin

P388 / Vincristin

P388 / Methotrexate

P388 / Mitoxantrone

Human

MT-1    breast / Adriablastin
MT-3    breast / Adriablastin
NCI      breast / Adriablastin
MCF-7  breast / Tamoxifen
MCF-7  breast / Adriablastin
MCF-7 / BCRP
MDA-MB 435 breast / Adriablastin
MDA-MB 231 / BCRP
3366 breast / Tamoxifen

 

 

Top


Copyright © 2007 of EPO GmbH - All rights reserved.     04. März 2008.